Pharmafile Logo
Pharmafocus logo
Advanced Search
mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

News

Abbvie and Biogen pull MS drug Zinbryta following urgent EMA safety review

March 5, 2018
Sales and Marketing AQbbvie, Biogen, EMA, Europe, mulyiple sclerosis, pharma, zinbryta

Biogen and Abbvie have announced their intention to voluntarily withdraw their multiple sclerosis therapy Zinbryta (daclizumab) from all global markets …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
endo-international

Endo granted injunction to block blood pressure competitor

March 2, 2018
Medical Communications, Sales and Marketing Endo, QuVa, Vasostrict, blood pressure, pharma, vasopressin

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …

News
diabetes-2424105_960_720

Study identifies five kinds of diabetes, potentially changing treatment

March 2, 2018
Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …

News
shutterstock_92671375

Artificial Cell Technologies CFO accused of stealing nearly $1m in company funds

March 2, 2018
Medical Communications, Sales and Marketing Artificial Cell Technologies, cfo, pharma

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …

News
phone_health

Novartis forms a Pear to develop mobile therapies

March 2, 2018
Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical

Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …

News
david_meek_web

Ipsen: Becoming a “development powerhouse”

March 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

Feature
takeda_usa_pharmaceuticals_u

Takeda to create 70 jobs with €25m Dublin investment

March 1, 2018
Manufacturing and Production Dublin, Takeda, pharma

Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a …

News
11149low_reception_in_darm

Merck/Pfizer’s Bavencio wins slight reprieve after NICE nod

March 1, 2018
Medical Communications, Sales and Marketing Bavencio, Merck, Pfizer, biotech, drugs, pharma, pharmaceutical

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …

News

Europe approves first therapy for haemophilia A with inhibitors in over 20 years

March 1, 2018
Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma

Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …

News
mylan_building

Mylan looks to muscle in on Allergan’s Botox territory

March 1, 2018
Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical

Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …

News
satu1028-pano_1024_px

EMA set to also revise guidelines of Alzheimer’s trials

February 28, 2018
Medical Communications Alzheimer's, EMA, FDA, biotech, drugs, pharma, pharmaceutical

The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …

News
anatomy-3003099_960_720

Stem cell therapy offers hope for spinal cord injuries

February 28, 2018
Research and Development biotech, drugs, pharma, pharmaceutical, stem cell, stem cell treatment

Scientists have brought the prospect of spinal cord injuries being able to be treated with stem cells one step closer, …

News
celgene_1_02

FDA refuses to review Celgene’s ozanimod in multiple sclerosis

February 28, 2018
Research and Development, Sales and Marketing Celgene, FDA, multiple sclerosis, ozanimod, pharma

Celgene has been dealt a heavy blow, revealing that the FDA has rejected its New Drug Application for its sphingosine …

News

AstraZeneca creates biotech spin-off, $250m in bank

February 28, 2018
Research and Development, Sales and Marketing AstraZeneca, Viela, biotech, drugs, pharma, pharmaceutical

Biotechs created from big pharma companies tend to have an easier start to life than most, and this is definitely …

News
pharmafocus_march_2018_cover

Pharmafocus March 2018 is available to read online now!

February 28, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …

News
dna

Generation Bio backed with $100m financing round

February 28, 2018
Research and Development, Sales and Marketing Generation Bio, biotech, drugs, pharma, pharmaceutical

At the start of year, Generation Bio was revealed to the public, announcing that it had been developing gene therapies …

News
nhs_sign

UK Government announces prescription price hike to record level

February 27, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing NHS, pharma, prescription, price

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …

News

Allergan’s patent gamble fails

February 27, 2018
Manufacturing and Production, Medical Communications Allergan, Mylan, biotech, drugs, patent, pharma, pharmaceutical

Allergan’s patent deal with the Saint Regis Mohawk Tribe, in an attempt to protect itself from an inter partes review …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026